Temporal Association Between Atrial Fibrillation Burden in Cardiac Implantable Electronic Devices and the Risk of Heart Failure Hospitalization

被引:2
|
作者
Ahluwalia, Nikhil [1 ]
Koehler, Jodi [2 ]
Sarkar, Shantanu [2 ]
Vasudevan, Neethu [2 ]
Majumder, Shubha [2 ]
Landman, Sean R. [2 ]
Schilling, Richard J. [1 ]
机构
[1] St Bartholomews Hosp, Barts Hlth NHS Trust, London, England
[2] Medtronic Inc, Mounds View, MN USA
关键词
atrial fibrillation; hospitalization; odds ratio; stroke; STRICT RATE CONTROL; TIME-COURSE; TACHYARRHYTHMIA; TACHYCARDIA; CARDIOMYOPATHY; ACCURACY; LENIENT;
D O I
10.1161/CIRCEP.124.012842
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Atrial fibrillation (AF) events in cardiac implantable electronic devices (CIEDs) are temporally associated with stroke risk. This study explores temporal differences in AF burden associated with HF hospitalization risk in patients with CIEDs. METHODS: Patients with HF events from the Optum de-identified Electronic Health Records from 2007 to 2021 and 120 days of preceding CIED-derived rhythm data from a linked manufacturer's data warehouse were included. AF burden >= 5.5 h/d was defined as an AF event. The AF event burden in the case period (days 1-30 immediately before the HF event) was considered temporally associated with the HF event and compared with the AF event burden in a temporally dissociated control period (days 91-120 before the HF event). The odds ratio for temporally associated HF events and the odds ratio associated with poorly rate-controlled AF (>110 bpm) were calculated. RESULTS: In total, 7257 HF events with prerequisite CIED data were included; 957 (13.2%) patients had AF events recorded only in either their case (763 [10.5%]) or control (194 [2.7%]) periods, but not both. The odds ratio for a temporally associated HF event was 3.93 (95% CI, 3.36-4.60). This was greater for an HF event with a longer stay of >3 days (odds ratio, 4.51 [95% CI, 3.57-5.68]). In patients with AF during both the control and case periods, poor AF rate control during the case period also increased HF event risk (1.78 [95% CI, 1.22-2.61]). In all, 222 of 4759 (5%) patients without AF events before their HF event had an AF event in the 10 days following. CONCLUSIONS: In a large real-world population of patients with CIED devices, AF burden was associated with HF hospitalization risk in the subsequent 30 days. The risk is increased with AF and an uncontrolled ventricular rate. Our findings support AF monitoring in CIED algorithms to prevent HF admissions.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Impact of Atrial Fibrillation Detected by Cardiac Implantable Electronic Devices on Embolic Stroke Events in Cancer Patients
    Nakano, Miyo
    Kondo, Yusuke
    Nakano, Masahiro
    Kajiyama, Takatsugu
    Ito, Ryo
    Chiba, Toshinori
    Sugawara, Masafumi
    Yoshino, Yutaka
    Ryuzaki, Satoko
    Komai, Yuya
    Takanashi, Yukiko
    Kobayashi, Yoshio
    CIRCULATION, 2023, 148
  • [32] Atrial fibrillation ablation success defined by duration of recurrence on cardiac implantable electronic devices
    Lohrmann, Graham
    Kaplan, Rachel
    Ziegler, Paul D.
    Monteiro, Joao
    Passman, Rod
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (12) : 3124 - 3131
  • [33] Impact of atrial fibrillation ablation on activity minutes in patients with cardiac implantable electronic devices
    Peigh, Graham
    Stanelle, Evan
    Ziegler, Paul D.
    Varberg, Nathan
    Soderlund, Dana
    Passman, Rod S.
    HEART RHYTHM, 2022, 19 (09) : 1405 - 1411
  • [34] Association between COVID-19 vaccination and atrial arrhythmias in individuals with cardiac implantable electronic devices
    Deshmukh, Abhishek J.
    Ahmad, Rimsha
    Cha, Yong-Mei
    Mulpuru, Siva K.
    DeSimone, Christopher V.
    Killu, Ammar M.
    Mullane, Steven
    Harrell, Camden
    Kutyifa, Valentina
    Cheung, Jim W.
    Upadhyay, Gaurav A.
    Piccini, Jonathan P.
    Hayes, David L.
    Madhavan, Malini
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2024, 35 (09) : 1828 - 1836
  • [35] Characteristics of successful termination of atrial fibrillation by atrial antitachycardia pacing in patients with cardiac implantable electronic devices
    Aizawa, Yoshiyasu
    Komura, Satoru
    Kawakami, Emiko
    Watanabe, Shonosuke
    Tanaka, Kazuki
    Kadowaki, Hiromu
    Takagi, Atsushi
    HEART AND VESSELS, 2024, 39 (10) : 884 - 890
  • [36] Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction
    Yang, Eunice
    Vaishnav, Joban
    Song, Evelyn
    Lee, Joan
    Schulman, Steven
    Calkins, Hugh
    Berger, Ronald
    Russell, Stuart D.
    Sharma, Kavita
    ESC HEART FAILURE, 2022, 9 (05): : 3918 - 2927
  • [37] Atrial High Rate Episodes in Patients with Dual-Chamber Cardiac Implantable Electronic Devices: Unmasking Silent Atrial Fibrillation
    Benezet-Mazuecos, Juan
    Manuel Rubio, Jose
    Farre, Jeronimo
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2014, 37 (08): : 1080 - 1086
  • [38] Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death
    Brady, Paul F.
    Chua, Winnie
    Nehaj, Frantisek
    Connolly, Derek L.
    Khashaba, Alya
    Purmah, Yanish J., V
    Ul-Qamar, Muhammad J.
    Thomas, Mark R.
    Varma, Chetan
    Schnabel, Renate B.
    Zeller, Tanja
    Fabritz, Larissa
    Kirchhof, Paulus F.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (04):
  • [39] Impact of New-Onset Atrial Fibrillation Detected by Cardiac Implantable Electronic Devices on Embolic Stroke Events
    Nakano, Miyo
    Kondo, Yusuke
    Nakano, Masahiro
    Kajiyama, Takatsugu
    Ito, Ryo
    Chiba, Toshinori
    Sugawara, Masafumi
    Yoshino, Yutaka
    Ryuzaki, Satoko
    Komai, Yuya
    Takanashi, Yukiko
    Kobayashi, Yoshio
    CIRCULATION, 2023, 148
  • [40] Outcomes of adjunct posterior wall isolation in atrial fibrillation patients with cardiac implantable electronic devices
    Aryana, Arash
    Thiemann, Anna M.
    Pujara, Deep K.
    Cossette, Laura L.
    Allen, Shelley L.
    Vierra, Eleanor C.
    Bowers, Mark R.
    Gandhavadi, Maheer
    Heath, Russell
    Trivedi, Amar D.
    O'Neill, Padraig Gearoid
    Ellis, Ethan R.
    d'Avila, Andre
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2023, 46 (07): : 563 - 573